Participants from all backgrounds (i.e., academics, water professionals, private sector practitioners and civil society stakeholders), who wish to present their work related to the theme and ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length ...
“Transcranial Alternating Current Stimulation for the Treatment of Anxiety: Preliminary Results from an Open-Label Pilot Clinical Trial” “Transcranial Alternating Current Stimulation for Comorbid ...
The ASCO Annual Meeting is widely regarded as the largest and most prestigious medical oncology conference in the world, attracting tens of thousands of leading oncologists, researchers, and ...
International Conference on Advances in Radiation Oncology (ICARO-4) - Abstract and Paper Submission
The purpose of the event is to discuss and define the current role and future potential of technological, medical physics and molecular/biological innovations for routine clinical practice in ...
Prepare a poster as per instructions above In addition, the presenter will have 3 minutes to share the research question(s), a brief overview of the data/methods and key findings in the form of slides ...
Abstracts for the 2024 Mississippi Water Resources Conference are due by Aug. 1. Standard oral presentations are a 25-minute slot, which includes time for an introduction and question-and-answer ...
TOPEKA, Kan. (WIBW) - The Governor’s Water Conference will highlight the latest policy and research developments on water issues in Kansas. According to the Kansas Water Office, the 13th annual ...
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, ...
Here you will find detailed information on the registration and abstract submission and links to the registration and submission forms. We only provide registrated for the whole duration of the ...
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of life Data to be presented include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results